Successful treatment of a case of relapsed acute promyelocytic leukemia with arsenic trioxide

被引：1

作者：

Hirayama, Y ^{[1
]}

Koyama, R ^{[1
]}

Nagai, T ^{[1
]}

Ohta, H ^{[1
]}

Kondo, A ^{[1
]}

Ishikawa, K ^{[1
]}

Ishitani, K ^{[1
]}

Matsunaga, T ^{[1
]}

Sakamaki, S ^{[1
]}

Niitsu, Y ^{[1
]}

机构：

[1] Hokkaido Prefectural Sapporo Kitano Hosp, Sapporo, Hokkaido, Japan

来源：

INTERNAL MEDICINE | 2001年 / 40卷 / 11期

关键词：

ATRA; skin erythema; neuralgia;

D O I：

10.2169/internalmedicine.40.1136

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

We report a patient with an initial relapse of acute promyelocytic leukemia (APL) who achieved a second complete remission (CR) after treatment with arsenic trioxide. The patient, a 66-year-old woman diagnosed as having relapsed APL, received arsenic trioxide intravenously at a dose of 10 mg/day. At day 36, the patient achieved a second CR. The side effects were slight neuralgia and mild skin erythematous changes, which improved following cessation of the drug. Although arsenic trioxide may be effective for relapsed APL, it should be used with caution because of various complications.

引用

页码：1136 / 1139

页数：4

共 50 条

[41] Successful treatment with arsenic trioxide of a patient with ATRA-resistant relapse of acute promyelocytic leukemia
Agis, H
Weltermann, A
Mitterbauer, G
Thalhammer, R
Edelhäuser, M
Seewann, HL
Valent, P
Lechner, K
Fonatsch, C
Geissler, K
ANNALS OF HEMATOLOGY, 1999, 78 (07) : 329 - 332
[42] Acute intestinal pseudo-obstruction after induction treatment of relapsed acute promyelocytic leukemia with arsenic trioxide
Park, Jeong A.
Yun, Jong Hyung
Kang, Hyoung In
Shin, Hee Young
Ahn, Hyo Seop
PEDIATRIC BLOOD & CANCER, 2008, 50 (04) : 872 - 874
[43] Carcinogenic risk of retained arsenic after successful treatment of acute promyelocytic leukemia with arsenic trioxide: a cause for concern?
Firkin, Frank
LEUKEMIA & LYMPHOMA, 2014, 55 (05) : 977 - 978
[44] Relapsed acute promyelocytic leukemia in a hemodialysis-dependent patient treated with arsenic trioxide: A case report
Emmons G.S.
Steingart R.H.
Stewart J.A.
Mertens W.C.
Journal of Medical Case Reports, 6 (1)
[45] COST-EFFECTIVENESS OF ARSENIC TRIOXIDE IN THE TREATMENT OF RELAPSED/REFRACTORY ACUTE PROMYELOCYTIC LYMPHOMA LEUKEMIA IN CANADA
Lachaine, J.
Mathurin, K.
Barakat, S.
VALUE IN HEALTH, 2014, 17 (03) : A84 - A84
[46] Role of Arsenic Trioxide in Acute Promyelocytic Leukemia
Iland, Harry J.
Seymour, John F.
CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2013, 14 (02) : 170 - 184
[47] Arsenic trioxide: Acute promyelocytic leukemia and beyond
Bachleitner-Hofmann, T
Kees, M
Gisslinger, H
LEUKEMIA & LYMPHOMA, 2002, 43 (08) : 1535 - 1540
[48] Parenthood in patients with acute promyelocytic leukemia after treatment with arsenic trioxide: a case series
Gupta, Shilpa
Bagel, Bhausaheb
Gujral, Sumeet
Subramanian, P. G.
Khattry, Navin
Menon, Hari
Nair, Reena
LEUKEMIA & LYMPHOMA, 2012, 53 (11) : 2192 - 2194
[49] Role of Arsenic Trioxide in Acute Promyelocytic Leukemia
Harry J. Iland
John F. Seymour
Current Treatment Options in Oncology, 2013, 14 : 170 - 184
[50] Use of arsenic trioxide in a hemodialysis-dependent patient with relapsed acute promyelocytic leukemia
Perreault, Sarah
Moeller, Julie
Patel, Kejal
Eyler, Rachel
Pham, Trinh
Russell, Kerry
Podoltsev, Nikolai
JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2016, 22 (04) : 646 - 651

← 1 2 3 4 5 →